You appear to be offline. Some data may be unavailable until your connection is restored.
BAX
StockBaxter International Inc
Price data not available
Description
Baxter International Inc. is a global healthcare company that develops, manufactures, and sells a broad range of medical products and technologies, including sterile intravenous solutions, infusion systems, parenteral nutrition, renal‑replacement therapies, and advanced surgical devices. It operates primarily in the medical‑device and pharmaceutical sectors, serving hospitals, dialysis centers, ambulatory surgery facilities, and home‑care settings worldwide. Baxter is recognized as a leading provider of renal‑care and infusion‑therapy products and is a prominent member of the S&P 500, competing with other major med‑tech firms such as Becton Dickinson, B. Braun, and Fresenius.
Quarterly EarningsQuarterly earnings results, including reported and estimated earnings per share (EPS), for the most recent fiscal quarters.Surprise compares reported EPS with the prior estimate.
| Quarter | DateReport date | EPSReported EPS |
|---|---|---|
| Q4 FY26 | Jan 28, 2027 (est.) | — |
| Q3 FY26 | Oct 29, 2026 | $0.58 |
| Q2 FY26 | Jul 30, 2026 | $0.56 |
| Q1 FY26 | Apr 30, 2026 | $0.36 |
| Q4 FY25 | Feb 12, 2026 | $0.44 |
Stay ahead of BAX earnings
Get reminders ahead of BAX's next earnings report, so you always know when results are coming.